Switching to systemic therapy after locoregional treatment failure: Definition and best timing

In patients with unresectable hepatocellular carcinoma (HCC) without both macrovascular invasion and extrahepatic metastasis, the initial treatment choice recommended is transarterial chemoembolization (TACE). Before sorafenib came into wide use, TACE had been pointlessly carried out repeatedly. It...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Mol Hepatol
Hlavní autoři: Ogasawara, Sadahisa, Ooka, Yoshihiko, Koroki, Keisuke, Maruta, Susumu, Kanzaki, Hiroaki, Kanayama, Kengo, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Saito, Tomoko, Kondo, Takayuki, Suzuki, Eiichiro, Nakamoto, Shingo, Tawada, Akinobu, Chiba, Tetsuhiro, Arai, Makoto, Kato, Jun, Kato, Naoya
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Association for the Study of the Liver 2020
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160341/
https://ncbi.nlm.nih.gov/pubmed/31937081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2019.0021n
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky